1
|
Wu L, Li Q, Deng J, Shen J, Xu W, Yang W, Chen B, Du Y, Zhang W, Ge F, Lei S, Li K, Wang Z. Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma. Int J Nanomedicine 2022; 16:8433-8446. [PMID: 35002237 PMCID: PMC8727453 DOI: 10.2147/ijn.s333279] [Citation(s) in RCA: 23] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2021] [Accepted: 12/05/2021] [Indexed: 01/18/2023] Open
Abstract
Purpose Cell membrane-camouflaged nanoparticles (NPs) are drawing increasing attention because their surfaces acquire some characteristics of the cell membranes, making them a unique class of biomimetic materials for diverse applications. Modification of cell membrane or combination of different types of membranes can enhance their functionality. Methods We prepared platelet and tumor cell membrane camouflaged β-mangostin-loaded NPs, which were synthesized with platelet–C6 hybrid biomimetic coating, poly(lactic-co-glycolic acid), and β-mangostin (β-PCNPs). Then, we evaluated their targeting ability and anticancer activity against glioma in vitro and in vivo. Results Biomimetic coating enhanced active drug targeting and immune escape properties of nanocarrier in C6 and THP-1 cells, respectively, which improved their cytotoxicity. β-PCNPs were characterized to study the inherent properties of both source cells. Compared with bare β-NPs, β-PCNPs exhibited high tumor-targeting capability and induced apoptosis of C6 cells in vitro. Similarly, intravenous administration of drug through β-PCNPs resulted in enhanced tumor-targeting and exhibited excellent rate of inhibition of glioma tumor growth in mice. Moreover, the blood circulation time of drug in mice in the β-PCNP group was markedly prolonged and these mice exhibited better outcome than those in the β-NP group. Conclusion These results provide a new strategy of utilizing PCNPs as carriers for drug delivery, which improves the targeting efficiency and therapeutic efficacy of chemotherapeutic agents for glioma therapy.
Collapse
Affiliation(s)
- Lingling Wu
- Department of Transfusion Medicine, Allergy Center, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College, Hangzhou, 310014, People's Republic of China.,Women's Hospital, School Of Medicine, Zhejiang University, Hangzhou, 310014, People's Republic of China
| | - Qin Li
- Department of Transfusion Medicine, Allergy Center, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College, Hangzhou, 310014, People's Republic of China
| | - Junjie Deng
- Zhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325000, People's Republic of China.,Oujiang Laboratory, Wenzhou, Zhejiang, 325000, People's Republic of China
| | - Jinglan Shen
- Department of Transfusion Medicine, Allergy Center, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College, Hangzhou, 310014, People's Republic of China
| | - Weide Xu
- Zhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325000, People's Republic of China
| | - Wei Yang
- Department of Biophysics, and Department of Neurosurgery of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China
| | - Bingyu Chen
- Department of Transfusion Medicine, Allergy Center, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College, Hangzhou, 310014, People's Republic of China
| | - Yaoqiang Du
- Department of Transfusion Medicine, Allergy Center, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College, Hangzhou, 310014, People's Republic of China
| | - Wei Zhang
- Hangzhou Chinese Academy of Sciences-Hangzhou Medical College Advanced Medical Technology Institute, Hangzhou, 310014, People's Republic of China
| | - Feihang Ge
- Hangzhou Chinese Academy of Sciences-Hangzhou Medical College Advanced Medical Technology Institute, Hangzhou, 310014, People's Republic of China
| | - Siyun Lei
- Department of Transfusion Medicine, Allergy Center, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College, Hangzhou, 310014, People's Republic of China
| | - Kaiqiang Li
- Department of Transfusion Medicine, Allergy Center, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College, Hangzhou, 310014, People's Republic of China
| | - Zhen Wang
- Department of Transfusion Medicine, Allergy Center, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College, Hangzhou, 310014, People's Republic of China
| |
Collapse
|